A detailed history of Marquette Asset Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Marquette Asset Management, LLC holds 53 shares of INCY stock, worth $5,519. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Previous 42 26.19%
Holding current value
$5,519
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

BUY
$83.8 - $108.26 $921 - $1,190
11 Added 26.19%
53 $5,000
Q3 2025

Oct 24, 2025

BUY
$67.27 - $86.96 $2,825 - $3,652
42 New
42 $3,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.